Scientists identify 1,700 unknown proteins hidden in the human dark proteome
An international consortium of more than 60 researchers has identified 1,785 previously unknown microproteins embedded in segments of human DNA long assumed to be functionally inert. The discovery, published Wednesday in the journal Nature, could expand the known human proteome by nearly 10 percent, representing one of the most significant additions to the catalog of human proteins in years.
The TransCODE Consortium, co-led by the Princess Máxima Center for Pediatric Oncology in the Netherlands, the University of Michigan Medical School, the EMBL European Bioinformatics Institute, and the Institute for Systems Biology in Seattle, analyzed 3.7 billion data points drawn from 95,520 experiments. The researchers focused on what scientists call the "dark proteome," a largely uncharted layer of genetic output encoded by non-canonical open reading frames that standard databases have historically overlooked. Of 7,264 sequences examined, approximately 25 percent produced detectable protein-like molecules.
The vast majority of these newly identified molecules are far smaller than conventional proteins. Some 65 percent contained fewer than 50 amino acids, compared with less than 1 percent of the roughly 19,500 proteins currently listed in standard reference databases. Only a dozen of the new molecules resembled traditional proteins closely enough to be classified alongside them. To accommodate the rest, the consortium introduced a new biological concept: the "peptidein," defined as a protein-like molecule whose functional role remains ambiguous. The term creates a third category between "protein" and "non-protein," giving these molecules a formal place in reference databases for future study rather than dismissing them outright.
The medical implications of the findings are particularly striking. Using large-scale CRISPR genomic editing, the team identified six peptideins that appear essential to the survival of cancer cells. One, encoded by a genetic sequence called OLMALINC previously assumed to produce no proteins at all, compromised the survival of 85 percent of more than 485 cancer cell lines tested when it was deactivated. Researchers confirmed the effect originated specifically from the peptidein itself and found that it plays a role in cell division and the response to DNA damage. Many of the newly detected peptideins appear on the surface of cells, where the immune system can recognize them, positioning them as potential targets for immunotherapy and cancer vaccines.
Researchers described the findings as the opening of a vast new scientific territory. Dr. John Prensner, a pediatric neuro-oncologist at the University of Michigan and co-lead of the study, said the work offers only a first glimpse of what the dark proteome may contain, comparing it to a film trailer for a broader, transformative understanding of human biology. Dr. Sebastiaan van Heesch of the Princess Máxima Center noted that peptideins are already central to several drug development initiatives and expressed confidence that making the full dataset openly available would accelerate the discovery of new therapeutic targets, including for cellular immunotherapies and cancer vaccines.
-
11:15
-
11:08
-
11:00
-
10:46
-
10:41
-
10:21
-
10:20
-
10:19
-
10:05
-
09:47
-
09:45
-
09:36
-
09:34
-
09:25
-
09:09
-
08:47
-
08:32
-
08:15
-
22:00
-
21:15
-
20:47
-
20:32
-
20:15
-
19:48
-
19:33
-
19:15
-
18:50
-
18:34
-
18:18
-
18:00
-
17:42
-
17:21
-
17:05
-
16:45
-
16:25
-
16:10
-
15:45
-
15:27
-
15:10
-
14:47
-
14:32
-
14:15
-
14:00
-
13:42
-
13:25
-
13:21
-
13:10
-
12:47
-
12:38
-
12:33
-
12:15
-
12:00
-
11:44
-
11:24
